NEW YORK (GenomeWeb News) – Arizona Heart Institute and Arizona Research Center will partner on cardiovascular research that will include genomics, epigenetics, and large, multi-center drug and medical device trials, AHI said today.

The collaboration, focused on heart and vascular diseases, will give AZRC access to patients that may qualify for pharmaceutical and device research studies, and will enable AHI to pursue epigenetic and genomic studies in efforts to develop early-stage diagnostics that could allow for interventions before symptoms present.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.